Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
162M
-
Number of holders
-
161
-
Total 13F shares, excl. options
-
147M
-
Shares change
-
+8.48M
-
Total reported value, excl. options
-
$2.77B
-
Value change
-
+$162M
-
Put/Call ratio
-
0.98
-
Number of buys
-
80
-
Number of sells
-
-67
-
Price
-
$18.88
Significant Holders of IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) as of Q2 2017
190 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK as of Q2 2017.
IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) has 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 147M shares
of 162M outstanding shares and own 90.65% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (18.7M shares), FMR LLC (18.7M shares), PRICE T ROWE ASSOCIATES INC /MD/ (16.4M shares), BlackRock Inc. (11.6M shares), VANGUARD GROUP INC (10.8M shares), JANUS HENDERSON GROUP PLC (7.97M shares), BROWN CAPITAL MANAGEMENT LLC (6.22M shares), ORBIMED ADVISORS LLC (5.76M shares), STATE STREET CORP (4.53M shares), and EcoR1 Capital, LLC (3.75M shares).
This table shows the top 161 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.